Obesity therapy and prevention by LRIG2 inhibition – a translational validation in a pig model
Worldwide, obesity and its associated diseases, mainly type 2 diabetes and cardiovascular disorders (hypertension, arteriosclerosis), represent strongly rising problems in humans. In 2016, the World Health Organization reported that more than 1.9 billion adults were overweight and of these, more than 650 million were obese. 18 million people die every year from the consequences of cardiovascular diseases and diabetes, and this accounts for about one third of all deaths worldwide.